CX3CR1 and attention deficit-hyperactivity disorder: Interestingly, we observed that the ADHD animal model presented a downregulation of the CX3CR1 protein levels (30.2 ± 9.1% of the control) in the retina, which was prevented by the MPH treatment (116.7 ± 14.2% of the control).